Skip to main content
Explore URMC



Diabetes In and Out


Saturday, March 12, 2016


University of Rochester School of Medicine & Dentistry
601 Elmwood Avenue
Rochester, NY   14642

Program Overview

The prevalence and incidence of diabetes is increasing worldwide.  In the United States, over 25 million people (8.3% of the population) have diabetes, 7 million of which have not been diagnosed.  There were 1.9 million new adult diagnoses in 2010 alone, and an alarming 79 million Americans are at risk of developing diabetes.  Type 2 is the most common form, affecting 90-95% of adults diagnosed with diabetes.  Diabetes is the seventh leading cause of mortality, and the risk of death amongst people with the disease is twice that of people without diabetes of a similar age.  Diabetes is also the leading cause of kidney failure, lower limb amputations, and blindness in the United States, and is one of the leading causes of heart disease and stroke.  Due to the complexity of the disease and its comorbidities, management of diabetes can be complicated.  The advent of new drugs and treatment options adds another layer of complexity, making it difficult for primary care providers to make decisions surrounding optimal treatment plans.  According to the Centers for Disease Control, approximately 60 percent of people with diabetes do not achieve their target blood sugar levels with their current treatment regiment. (4)(Saydah SH, Fradkin J and Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-42) The financial burden of diabetes is huge: total treatment costs in the United States add up to approximately $179 million per year.

Unfortunately, Monroe County is behind the curve with regards to the diagnosis and treatment of diabetes.  According to the CDC, 8.5% of adults in Monroe County have been diagnosed with Diabetes and 30% of adults in Monroe County are considered to be obese. (Centers for Disease Control and Prevention: National Diabetes Surveillance System. Available online at: Retrieved 6/8/2012). The shortage of endocrinologists in Rochester and surrounding areas (there are approximately 12 full-time endocrinologists, or one endocrinologist for every 6900 individuals with diabetes), means that primary care providers in this region carry the burden of trying to prevent, diagnose and treat diabetes and its associated complications.

In 2012, the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) joined forces to examine the evidence and develop recommendations surrounding antihyperglycemic therapy in non-pregnant adults with T2DM. Updates to the most recent guidelines were deemed necessary because of the growing complexity and controversy surrounding contemporary glycemic management in persons with type 2 diabetes.  There has been new information surrounding benefits/risks of glycemic control, the safety and efficacy of new classes of drugs, withdrawal or restriction of other drugs, and the recognition that many people with diabetes will need multiple agents in order to bring the disease under control.  There has also been a push for patient centered care in the treatment of diabetes, due in part to the fact that with this disease in particular, it is patients who ultimately decide whether and what lifestyle changes to make and what treatment options they adhere to.  Researchers also feel that patients are more likely to follow through on treatment protocols when they are involved in developing treatment plans.

This educational activity will provide primary care physicians, pediatricians, mid-level providers, endocrinologists, nephrologists, dieticians, and other allied health professionals with updates in diabetes research and treatment options.  Topics will cover diabetes education teaching methods, the diabetic diet, mental illness and diabetes, treatment of obesity, hypertension, and metabolic syndrome in diabetes, care for the inpatient diabetic or the outpatient diabetic facing surgery, and new insulin and hypoglycemic agents that can be used to treat diabetes.

At the conclusion of this activity, participants should be able to:
 - Explain the goals and methods toward treatment of obesity, hypertension, and hyperlipidemia in diabetic patients
 - Identify appropriate approaches to managing mental illness in patients with diabetes
 - Teach diabetes patients the basics on education and nutrition
 - Manage the care of hospitalized diabetes patients or patients who will require surgical procedures
 - Identify the pros and cons new insulins and oral agents available to treat diabetes

Link to:

Certification / Accreditation
Faculty / Speakers
Location / Parking
Registration Fees
Conference support
Speaker Presentations

Please contact the Center for Experiential Learning at 585-275-7666 with any questions, concerns or require assistance with online Registration.

                                 Register for this Event